Drugs / BI 653048
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02217631 | Oct 2009 → Mar 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02217644 | Nov 2008 → Jun 2009 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 653048 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02217644 ↗ |
| Action | Activate | “functionally selective glucocorticoid receptor agonist BI 653048” PMID 30908082 ↗ Apr 2019 |
| Modality | Small molecule | — CHEMBL3358954 ↗ |
| Route | Oral | “BI 653048 H3PO4 Oral Drinking Solution” NCT02217644 ↗ |